| TERNS PHARMACEUTICALS |
| USA |
| Gesundheit |
| US8808811074 / A2QNWR |
| 430 (Frankfurt) / TERN (NASDAQ) |
| FRA:430, ETR:430, 430:GR, NASDAQ:TERN |
| - |
| https://www.ternspharma.c.. |
|
Terns Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic candidates targeting liver disease and oncology. Its primary function is to ad..
>Volltext.. |
| 4545.14 Mio. EUR |
| 4293.9 Mio. EUR |
| - |
| -92.95 Mio. EUR |
| -81.37 Mio. EUR |
| -0.89 EUR |
| 0.89 Mio. EUR |
| 129.85 Mio. EUR |
| -67.2 Mio. EUR |
| 19.21 |
| - |
| -1.74% |
| - |
| - |
| - |
| TERNS PHARMACEUTICALS, TERNS PHARMA, TERNS PHARMACEUTICAL |
| 25.03.26 |
|